Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner

Introduction Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	BMC urology Ročník 23; číslo 1; s. 69 - 6
Hlavní autoři:	Sharqawi, Abdallah, Drye, Naomi, Shugaba, Abdul, O’reilly, Alison, Kadry, Ahmed M., El-Sakka, A I
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 28.04.2023 BioMed Central Ltd Springer Nature B.V BMC
Témata:	Biopsy Clinical significance Clinical trials Clinically significant prostate cancer Family medical history Humans Image-Guided Biopsy - methods Internal Medicine Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Medical research Medicine Medicine & Public Health Medicine, Experimental Multiparametric Magnetic Resonance Imaging Patients Perineum PI-RADS score Prostate - pathology Prostate cancer Prostatic Neoplasms - pathology Reproducibility of Results Retrospective Studies Statistical analysis Trans perineal prostate biopsy Urology Clinically significant prostate cancer Multiparametric magnetic resonance imaging Trans perineal prostate biopsy PI-RADS score
ISSN:	1471-2490, 1471-2490
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!